Literature DB >> 15710493

Type IX collagen knock-out mouse shows progressive hearing loss.

Nobuyoshi Suzuki1, Kenji Asamura, Yasutake Kikuchi, Yutaka Takumi, Satoko Abe, Yasutada Imamura, Toshihiko Hayashi, Attila Aszodi, Reinhard Fässler, Shin-ichi Usami.   

Abstract

Type IX collagen is one of the important components, together with type II, V, and XI collagens, in the tectorial membrane of the organ of Corti. To confirm the significance of type IX collagen for normal hearing, we assessed the detailed morphological and electrophysiological features of type IX collagen knock-out mice, which have recently been reported as a deafness model. Through assessment by auditory brainstem response (ABR), knock-out mice were shown to have progressive hearing loss. At the light microscopic level, the tectorial membrane of knock-out mice was found to be abnormal in shape. These morphological changes started in the basal turn and were progressive toward the apical turn. Electron microscopy confirmed disturbance of organization of the collagen fibrils. These results suggest that mutations in type IX collagen genes may lead to abnormal integrity of collagen fibers in the tectorial membrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710493     DOI: 10.1016/j.neures.2004.12.001

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  18 in total

1.  Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.

Authors:  Sherri M Jones; Nahid G Robertson; Shelly Given; Anne B S Giersch; M Charles Liberman; Cynthia C Morton
Journal:  Hear Res       Date:  2010-11-10       Impact factor: 3.208

2.  Characterization of an abundant COL9A1 transcript in the cochlea with a novel 3' UTR: Expression studies and detection of miRNA target sequence.

Authors:  Theru A Sivakumaran; Barbara L Resendes; Nahid G Robertson; Anne B S Giersch; Cynthia C Morton
Journal:  J Assoc Res Otolaryngol       Date:  2006-04-19

3.  Decreased physical function and increased pain sensitivity in mice deficient for type IX collagen.

Authors:  Kyle D Allen; Timothy M Griffin; Ramona M Rodriguiz; William C Wetsel; Virginia B Kraus; Janet L Huebner; Lawrence M Boyd; Lori A Setton
Journal:  Arthritis Rheum       Date:  2009-09

4.  Electrokinetic properties of the mammalian tectorial membrane.

Authors:  Roozbeh Ghaffari; Scott L Page; Shirin Farrahi; Jonathan B Sellon; Dennis M Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

5.  Porosity controls spread of excitation in tectorial membrane traveling waves.

Authors:  Jonathan B Sellon; Roozbeh Ghaffari; Shirin Farrahi; Guy P Richardson; Dennis M Freeman
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

6.  Signatures from tissue-specific MPSS libraries identify transcripts preferentially expressed in the mouse inner ear.

Authors:  Linda M Peters; Inna A Belyantseva; Ayala Lagziel; James F Battey; Thomas B Friedman; Robert J Morell
Journal:  Genomics       Date:  2006-10-17       Impact factor: 5.736

7.  Locomotor activity and gait in aged mice deficient for type IX collagen.

Authors:  Kerry E Costello; Farshid Guilak; Lori A Setton; Timothy M Griffin
Journal:  J Appl Physiol (1985)       Date:  2010-04-01

Review 8.  Inheritance patterns of progressive hearing loss in laboratory strains of mice.

Authors:  Konrad Noben-Trauth; Kenneth R Johnson
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

Review 9.  Genetics of hearing and deafness.

Authors:  Simon Angeli; Xi Lin; Xue Zhong Liu
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

10.  The role of mtDNA mutations in the pathogenesis of age-related hearing loss in mice carrying a mutator DNA polymerase gamma.

Authors:  Shinichi Someya; Tatsuya Yamasoba; Gregory C Kujoth; Thomas D Pugh; Richard Weindruch; Masaru Tanokura; Tomas A Prolla
Journal:  Neurobiol Aging       Date:  2007-03-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.